A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

NCT04269395 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

125

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated early as per Sponsor's decision

Conditions

Keratosis, Actinic

Interventions

DRUG: MAL Cream
DRUG: Vehicle cream

Sponsor

Galderma R&D